September 16, 2023 (Vientiane) Laos BIGBEAR Pharmaceuticals announced has recently made a significant stride in the field of immune inflammatory disease treatment with the approval of four breakthrough Janus kinase (JAK) inhibitors. The Lao Health Authority has given the green light to TOFADX, RUSODX, UPADX, and DUVACIDX, marking a new…
The Food and Drug Department of the Ministry of Health in Lao PDR is responsible for regulating the registration of pharmaceutical products in the country . They provide a range of forms and guidelines on their website to assist with the registration process . For instance, you can download the…
Vientiane, Laos - April 28, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative therapies for cancer, announced today that it has received approval from the Ministry of Health of Laos for six anti-cancer targeted drugs. The approved drugs are: The approval of these…
VIENTIANE, LAO PDR, March 6, 2023 -- The Lao Ministry of Health and the World Health Organization hosted an important GMP quality improvement meeting in Vientiane on March 1, attended by professionals from the local pharmaceutical industry. The purpose of this conference is to improve the quality of medicines in…
VIENTIANE, VIENTIANE, LAO PDR, March 3, 2023 -- BigBear pharmaceutical.LTD (BigBear pharma) announced that it has obtained the Good Manufacturing Practices (GMP) certificate issued by the Lao Food and Drug Regulatory Authority. The investor team of BigBear pharmaceutical went to Laos to investigate the investment environment in 2021, and formally…
Laos BIGBEAR Pharma’s Advanced JAK Inhibitor Pipeline:…How to inquire about the product registration information of…
15 fármacos dirigidos para el cáncer de mama her2 negativo
2 targeted drugs for the treatment of BRAF V600 mutation-pos…2 fármacos dirigidos para el tratamiento del cáncer de pulmó…
Copyright © 2021-2022 LienTeh.net All rights reserved.
